Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 31 tags : Research save search
Real-World Clinical Utility Study Published in Cancer Investigation Demonstrates the Impact of DecisionDx®-SCC Test Results in Guiding Risk-Aligned Care for Patients with Cutaneous Squamous Cell Carcinoma
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
CSTL | $19.2 1.91% 1.82% 140K
|
Health Technology
|
| O: -0.85%
H: 13.95%
C: 9.86%
decisiondx care test impact cancer study cell carcinoma
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -0.31%
H: 2.7%
C: 1.15%
topline trial positive results
National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
CTSO | $0.801 1.39% 1.39% 97K
|
Health Technology
|
| O: 0.57%
H: 12.0%
C: 6.86%
test health removal grants
Ardelyx Collaboration Partner, Kyowa Kirin, Announces Submission of New Drug Application for Tenapanor for Hyperphosphatemia in Japan
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
ARDX | News | $6.44 -1.68% -1.63% 2.9M
|
Health Technology
|
| O: 0.69%
H: 7.53%
C: 2.74%
tenapanor drug hyperphosphatemia japan collaboration application submission
Biomea Fusion Announces Dosing of First Patient with Type 2 Diabetes and Completion of Phase I Healthy Volunteer Portion of Phase I/II (COVALENT-111) Study of BMF-219
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
BMEA | $11.16 -2.96% -2.86% 1.7M
|
Professional, Scientific, and T...
|
| O: -2.33%
H: 11.75%
C: 9.56%
alent-111 bmf-219 diabetes study
Instil Bio Announces Voluntary Pause of Enrollment in Ongoing Clinical Trials Related to Manufacturing
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
TIL | $10.41 -1.65% -1.68% 7.5K
|
Professional, Scientific, and T...
|
| O: -34.67%
H: 16.91%
C: -3.79%
ongoing trials
Reviva Pharmaceuticals Announces Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia
Published: 2022-10-31 (Crawled : 16:00) - biospace.com/
RVPH | $3.02 -5.63% -5.61% 120K
|
|
| O: 0.0%
H: 18.42%
C: 3.16%
pharmaceuticals global brilaroxazine schizophrenia update study
Players In The Carbon Footprint Management Market Are Using Blockchain Technology To Improve Carbon Traceability: The Business Research Company
Published: 2022-10-31 (Crawled : 16:00) - prnewswire.com
SAPGF | News | $181.104 2.46% -19.46% 1.2K
|
Technology Services
|
| O: -2.57%
H: 2.86%
C: 0.87%
SAP | News | $178.64 -0.72% 0.13% 1.5M
|
Technology Services
|
| O: -1.26%
H: 0.42%
C: -0.44%
ACN | $316.0 0.46% -0.2% 2.6M
|
Technology Services
|
| O: -1.49%
H: 1.57%
C: 0.15%
management research blockchain technology market
Ainos Pursues Licensing Partners to Accelerate Five Candidates of its Low-dose Oral Interferon Formulation VELDONA to Phase 3 Trials and Commercialization
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
AIMD | $1.03 -0.96% 1.92% 10K
|
Manufacturing
|
| O: 2.5%
H: 0.72%
C: -7.32%
trials commercialization
Ensysce Biosciences Announces Positive Topline Results of Clinical Study Evaluating Human Abuse Potential of Intranasal Administration of PF614, a TAAP Abuse-Deterrent Oxycodone Extended-Release Product
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
ENSC | $0.5802 -7.88% -8.49% 89K
|
Health Technology
|
| O: -2.32%
H: 0.26%
C: -14.78%
pf614 topline potential positive results study
Loulou Foundation announces First-Patient-In for CANDID observational study on CDKL5 Deficiency Disorder
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
BIIB | $190.52 -0.85% -0.84% 1.3M
|
Health Technology
|
| O: -0.36%
H: 0.36%
C: 0.06%
study
Alzamend Neuro Receives FDA “Study May Proceed” Letter for Phase I/IIA Trial Under Its Investigational New Drug Application for an Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
ALZN | $0.691 -4.57% -4.79% 28K
|
Professional, Scientific, and T...
|
| O: 1.77%
H: 6.09%
C: 1.74%
alzn002 fda dementia drug immunotherapy vaccine application trial alzheimer’s
Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
fda heart approval
Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners
Published: 2022-10-31 (Crawled : 15:00) - biospace.com/
MS | News 0 d | $90.26 0.2% -0.31% 5.1M
|
Finance
|
| O: -0.55%
H: 1.94%
C: 0.49%
MRNS | $1.41 -2.08% -2.13% 4.6M
|
Health Technology
|
| O: 0.0%
H: 6.76%
C: 2.31%
pharmaceuticals agreement
DM Clinical Research Honored for Excellence in Patient Centricity
Published: 2022-10-31 (Crawled : 14:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: -5.14%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
research
Sports, Movies, Celebrities and Beyond: New Report From Stagwell's (STGW) National Research Group Shows 'Brands' Fuel the Fan Ecosystem
Published: 2022-10-31 (Crawled : 13:20) - prnewswire.com
STGW | News F | $5.54 4.33% 3.98% 430K
|
|
| O: -0.66%
H: 1.59%
C: 0.26%
research report group
Polymer Emulsions Market to Garner $56.3 Billion, Globally, By 2031 at 7.6% CAGR, Says Allied Market Research
Published: 2022-10-31 (Crawled : 13:20) - prnewswire.com
DOW | News A | $56.49 -0.58% 0.0% 3.9M
|
Process Industries
|
| O: 0.0%
H: 0.72%
C: -1.56%
CE | News | $154.62 0.08% 0.0% 410K
|
Process Industries
|
| O: -0.59%
H: 1.36%
C: 0.62%
research market
IBM Announces Demonstration Project with U.S. Patent and Trademark Office to Help Make Patent Research Insights More Accessible and Usable
Published: 2022-10-31 (Crawled : 13:00) - prnewswire.com
IBM | $181.47 -0.89% -0.53% 2.3M
|
Technology Services
|
| O: -0.32%
H: 0.51%
C: 0.17%
patent research
Ceramic Fiber Market Worth USD 4432.5 Million by 2028 at a CAGR of 9.8% - Report by Brandessence Market Research
Published: 2022-10-31 (Crawled : 12:00) - prnewswire.com
MEOH | $47.52 -0.81% -0.86% 310K
|
Process Industries
|
| O: -0.59%
H: 3.67%
C: 3.22%
research report market
Mizuho Americas Hires Nitin Kumar, CFA as Senior Energy Equity Research Analyst
Published: 2022-10-31 (Crawled : 12:00) - globenewswire.com
MFG | $3.84 1.05% 0.0% 860K
|
Finance
|
| O: 0.0%
H: 0.23%
C: -0.92%
research energy
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.